Biovica begins trading in subscription rights for rights issue
Bitget2026/10/06 13:01Biovica published a share issue memorandum for a rights issue, outlining terms for the issuance of subscription rights. Subscription rights accrue to shareholders on the Oct. 5, 2026 record date. Subscription runs Oct. 7–21, 2026. Subscription rights trade Oct. 7–16, 2026. Paid subscribed shares (BTA) trade Oct. 7–28, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biovica International AB published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.
- Biovica published a share issue memorandum for a rights issue, outlining terms for the issuance of subscription rights.
- Subscription rights accrue to shareholders on the Oct. 5, 2026 record date.
- Subscription runs Oct. 7–21, 2026.
- Subscription rights trade Oct. 7–16, 2026.
- Paid subscribed shares (BTA) trade Oct. 7–28, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
JPMorgan raises AbbVie target price to $300
Crypto prices
More
